Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aspa Therapeutics

Clinical trials sponsored by Aspa Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental gene therapy hopes to slow rare brain disease in toddlers Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

Experimental gene therapy hopes to slow rare brain disease in toddlers

Disease control Recruiting now

This study tests a gene therapy called BBP-812 in children up to 30 months old with Canavan disease, a rare genetic brain disorder. The treatment uses a harmless virus to deliver a working copy of the ASPA gene, aiming to reduce harmful brain chemicals and improve motor and think…

Phase 1/2 • Sponsor: Aspa Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC